Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome

被引：4
|
作者：
Torti, Lorenza [1 ]
Larocca, Luigi M. [2 ]
Massini, Giuseppina [1 ]
Cuccaro, Annarosa [1 ]
Maiolo, Elena [1 ]
Santangelo, Rosaria [3 ]
Bianchi, Maria [1 ]
Pennisi, Mariano Alberto [4 ]
Hohaus, Stefan [1 ]
Teofili, Luciana [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Hematol, Largo Gemelli 8, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dept Pathol, Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Microbiol, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Dept Anaesthesiol, Rome, Italy
来源：
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES | 2012年 / 4卷 / 01期
关键词：
D O I：
10.4084/MJHID.2012.008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We describe the case of a 17- year old female who developed fatal haemophagocytic syndrome (HPS) one month following acute infection caused by Epstein-Barr virus (EBV). Despite initiation of treatment and reduction of EBV load, laboratory signs of HPS as severe cytopenia, hypofibrinogenemia, hyperferritinemia and hypertriglyceridemia persisted, and the patient died of multiorgan failure. HPS is a rare, but life-threatening complication of EBV infection.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Haemophagocytic syndrome associated with Epstein-Barr virus infection and promoted by tuberculosis reactivation in a patient undergoing chronic haemodialysis
    Ye, CL
    Mizoguchi, Y
    Tomita, M
    Shinzato, M
    Kuroda, M
    Shamoto, M
    Kasahara, M
    Matsuyama, M
    Matsuura, A
    NEPHROLOGY, 2002, 7 (02) : 61 - 65
  • [42] Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis
    Song, Yue
    Wang, Yini
    Wang, Zhao
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (05) : 717 - 723
  • [43] Lenalidomide (LEN) and Epstein-Barr Virus (EBV) Reactivation
    Mezo, Melinda
    Bjorklund, Chad C.
    Weiss, Lilia
    Minton, Neil
    Freeman, John
    BLOOD, 2015, 126 (23)
  • [44] CHRONIC RECURRENT EPSTEIN-BARR VIRUS (EBV) INFECTIONS
    JONES, JF
    FRIEDMAN, AD
    LARSON, GR
    CLINICAL RESEARCH, 1983, 31 (01): : A122 - A122
  • [45] EPSTEIN-BARR VIRUS (EBV) DNA-REPLICATION IN EBV-ASSOCIATED LYMPHOPROLIFERATIVE LESIONS
    KATZ, BZ
    RAABTRAUB, N
    HO, M
    MILLER, G
    CLINICAL RESEARCH, 1988, 36 (03): : A781 - A781
  • [46] Plasma Epstein-Barr virus (EBV) DNA as a biomarker for EBV-associated Hodgkin lymphoma
    Dinand, Veronique
    Sachdeva, Anupam
    Datta, Sanghamitra
    Bhalla, Sunita
    Kalra, Manas
    Wattal, Chand
    Radhakrishnan, Nita
    INDIAN PEDIATRICS, 2015, 52 (08) : 681 - 685
  • [47] The presence of defective Epstein-Barr virus (EBV) infection in EBV-associated hematological malignancies
    Okuno, Yusuke
    Murata, Takayuki
    Sato, Yoshitaka
    Ito, Yoshinori
    Yoshida, Kenichi
    Sawada, Akihisa
    Shiraishi, Yuichi
    Miyano, Satoru
    Takahashi, Yoshiyuki
    Kojima, Seiji
    Ogawa, Seishi
    Kimura, Hiroshi
    CANCER SCIENCE, 2018, 109 : 642 - 642
  • [48] Plasma Epstein-Barr virus (EBV) DNA as a biomarker for EBV-associated Hodgkin lymphoma
    Veronique Dinand
    Anupam Sachdeva
    Sanghamitra Datta
    Sunita Bhalla
    Manas Kalra
    Chand Wattal
    Nita Radhakrishnan
    Indian Pediatrics, 2015, 52 : 681 - 685
  • [49] TRANSMISSION OF EPSTEIN-BARR VIRUS (EBV) BY TRANSFUSION OF BLOOD
    FLEISHER, GR
    PEDIATRIC RESEARCH, 1985, 19 (04) : A293 - A293
  • [50] Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
    Kerr, Jonathan R.
    JOURNAL OF CLINICAL PATHOLOGY, 2019, 72 (10) : 651 - 658
12345